Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data

References

• World Health Organization. Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec. 2011;86(24):241–256.
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control. Factsheet about tick-borne encephalitis (TBE) [Internet]. Solna Sweden: ECDC; [cited 2023 Jul 11]. Available from: https://www.ecdc.europa.eu/en/tick-borne-encephalitis/facts/factsheet
   Google Scholar
• Postler TS, Beer M, Blitvich BJ, et al. Renaming of the genus flavivirus to orthoflavivirus and extension of binomial species names within the family flaviviridae. Arch Virol. 2023;168(9):224. doi: 10.1007/s00705-023-05835-1
   PubMed Web of Science ®Google Scholar
• Hills S, Gould C, Cossaboom C. Tick-borne encephalitis CDC yellow book 2024 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2023 [cited 2023 Jul 11]. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/tick-borne-encephalitis
   Google Scholar
• Kovalev SY, Mukhacheva TA. Reconsidering the classification of tick-borne encephalitis virus within the Siberian subtype gives new insights into its evolutionary history. Infect Genet Evol. 2017;55:159–165. doi: 10.1016/j.meegid.2017.09.014
   PubMed Web of Science ®Google Scholar
• Tkachev SE, Chicherina GS, Golovljova I, et al. New genetic lineage within the Siberian subtype of tick-borne encephalitis virus found in Western Siberia, Russia. Infect Genet Evol. 2017;56:36–43. doi: 10.1016/j.meegid.2017.10.020
   PubMed Web of Science ®Google Scholar
• Dai X, Shang G, Lu S, et al. A new subtype of eastern tick-borne encephalitis virus discovered in Qinghai-Tibet Plateau, China. Emerg Microbes Infect. 2018;7(1):74. doi: 10.1038/s41426-018-0081-6
   PubMedGoogle Scholar
• Nygren TM, Pilic A, Böhmer MM, et al. Recovery and sequelae in 523 adults and children with tick-borne encephalitis in Germany. Infection. 2023;51(5):1503–1511. doi: 10.1007/s15010-023-02023-w
   PubMed Web of Science ®Google Scholar
• Steffen R. Tick-borne encephalitis (TBE) in children in Europe: epidemiology, clinical outcome and comparison of vaccination recommendations. Ticks Tick Borne Dis. 2019;10(1):100–110. doi: 10.1016/j.ttbdis.2018.08.003
   PubMed Web of Science ®Google Scholar
• Czupryna P, Grygorczuk S, Krawczuk K, et al. Sequelae of tick-borne encephalitis in retrospective analysis of 1072 patients. Epidemiol Infect. 2018;146(13):1663–1670. doi: 10.1017/S0950268818002005
   PubMed Web of Science ®Google Scholar
• Veje M, Nolskog P, Petzold M, et al. Tick-borne encephalitis sequelae at long-term follow-up: a self-reported case–control study. Acta Neurol Scand. 2016;134(6):434–441. doi: 10.1111/ane.12561
   PubMed Web of Science ®Google Scholar
• Engman M-L, Lindström K, Sallamba M, et al. One-year follow-up of tick-borne central nervous system infections in childhood. Pediatr Infect Dis J. 2012;31(6):570–574. doi: 10.1097/INF.0b013e31824f23c0
   PubMed Web of Science ®Google Scholar
• Fowler Å, Forsman L, Eriksson M, et al. Tick-borne encephalitis carries a high risk of incomplete recovery in children. J Pediatr. 2013;163(2):555–560. doi: 10.1016/j.jpeds.2013.01.037
   PubMed Web of Science ®Google Scholar
• Christie S, Chan V, Mollayeva T, et al. Systematic review of rehabilitation intervention outcomes of adult and paediatric patients with infectious encephalitis. BMJ Open. 2018;8(5):e015928. doi: 10.1136/bmjopen-2017-015928
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Tick-borne encephalitis [Internet]. Atlanta (GA): CDC; 2022 [cited 2023 Jul 31]. Available from: https://wwwnc.cdc.gov/travel/diseases/tickborne-encephalitis
   Google Scholar
• Kunz C. TBE vaccination and the Austrian experience. Vaccine. 2003;21(Suppl 1):S50–S55. doi: 10.1016/S0264-410X(02)00813-7
   PubMedGoogle Scholar
• Heinz FX, Stiasny K, Holzmann H, et al. Emergence of tick-borne encephalitis in new endemic areas in Austria: 42 years of surveillance. Euro Surveill. 2015;20(13):9–16. doi: 10.2807/1560-7917.ES2015.20.13.21077
   PubMedGoogle Scholar
• Erber W, Schmitt H-J. Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: results from a cross-sectional study. Ticks Tick Borne Dis. 2018;9(4):768–777. doi: 10.1016/j.ttbdis.2018.02.007
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Tick-borne encephalitis - Annual Epidemiological Report for 2020 [Internet]. Solna Sweden: ECDC; 2022 [cited 2023 Jul 11]. Available from: https://www.ecdc.europa.eu/en/publications-data/tick-borne-encephalitis-annual-epidemiological-report-2020
   Google Scholar
• De Pelsmaeker N, Korslund L, Ø S. High-elevational occurrence of two tick species, ixodes ricinus and I. trianguliceps, at their northern distribution range. Parasites Vectors. 2021;14(1):161. doi: 10.1186/s13071-021-04604-w
   PubMed Web of Science ®Google Scholar
• Mansbridge CT, Osborne J, Holding M, et al. Autochthonous tick-borne encephalitis in the United Kingdom: a second probable human case and local eco-epidemiological findings. Ticks Tick Borne Dis. 2022;13(1):101853. doi: 10.1016/j.ttbdis.2021.101853
   PubMed Web of Science ®Google Scholar
• Lang D, Chitimia-Dobler L, Bestehorn-Willmann M, et al. The emergence and dynamics of tick-borne encephalitis virus in a new endemic region in southern Germany. Microorganisms. 2022;10(11):2125. doi: 10.3390/microorganisms10112125
   PubMed Web of Science ®Google Scholar
• Robert Koch Institut. Epidemiologisches Bulletin 9/2022 [Internet]. Berlin: RKI; 2022 [cited 2023 Jul 11]. Available from: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/09_22.pdf?__blob=publicationFile
   Google Scholar
• Mahase E. UK confirms two cases of tickborne encephalitis acquired within the country. BMJ. 2023;381:799. doi: 10.1136/bmj.p799
   PubMedGoogle Scholar
• Pilz A, Erber W, Schmitt H-J. Vaccine uptake in 20 countries in Europe 2020: focus on tick-borne encephalitis (TBE). Ticks Tick Borne Dis. 2023;14(1):102059. doi: 10.1016/j.ttbdis.2022.102059
   PubMed Web of Science ®Google Scholar
• Šmit R, Postma MJ. Review of tick-borne encephalitis and vaccines: clinical and economical aspects. Expert Rev Vaccines. 2015;14(5):737–747. doi: 10.1586/14760584.2015.985661
   PubMed Web of Science ®Google Scholar
• Bavarian Nordic. About ENCEPUR. [cited 2024 Jan 5]. Available from: https://bnvaccines.com/en-SE/product/about-encepur
   Google Scholar
• Electronic Medicines Compendium. TicoVac 0.5 ml suspension for injection in a prefilled syringe [Internet]. Leatherhead (UK): Datapharm; 2021 [cited 2023 Jul 31]. Available from: https://www.medicines.org.uk/emc/product/1923/smpc
   Google Scholar
• Amicizia D, Domnich A, Panatto D, et al. Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines. Hum Vaccin Immunother. 2013;9(5):1163–1171. doi: 10.4161/hv.23802
   PubMed Web of Science ®Google Scholar
• Heinz FX, Holzmann H, Essl A, et al. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine. 2007;25(43):7559–7567. doi: 10.1016/j.vaccine.2007.08.024
   PubMed Web of Science ®Google Scholar
• Bavarian Nordic. Encepur Dosing [Internet]. Hellerup Denmark: Bavarian Nordic; 2023 [cited 2023 Jul 11]. Available from: https://bnvaccines.com/product/encepur/encepur-dosing
   Google Scholar
• Bundesamt für Gesundheit BAG. Empfehlungen zur Impfung gegen Zeckenenzephalitis. Bundesamt für Gesundheit. Bull. OFSP 13: 225–231 [Internet]. Bern: BAG; 2006 [cited 2023 Jul 11]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/richtlinien-empfehlungen/empfehlungen-spezifische-erreger-krankheiten/zeckenenzephalitis/zeckenenzephalitis-empfehlung-impfung.pdf.download.pdf/fsme-bu1306-d.pdf
   Google Scholar
• Terveyden ja hyvinvoinnin laitos. TBE-rokote eli “punkkirokote” [Internet]. Helsinki: THL; 2023 [cited 2023 Jul 11]. Available from: https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/tbe-rokote-eli-punkkirokote
   Google Scholar
• Conseil Supérieur de la Santé. Vaccination contre l’encéphalite à tiques (TBE). CSS. Avis n° 9435 [Internet]. Brussels: CSS; 2019 [cited 2023 Jul 11]. Available from: https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/css_9435_tbe.pdf
   Google Scholar
• Kind A, Ritzmann P, Marty F, et al. Der Impfschutz gegen die Zeckenenzephalitis hält viel länger als bisher angenommen. Z Allg Med. 2008;84(4):153–156. doi: 10.1055/s-2007-1004536
   Google Scholar
• Terveyden ja hyvinvoinnin laitos. Pitäisikö TBE-rokotusohjelmaa laajentaa? Työpaperi 44/2013 [Internet]. Helsinki: THL; 2013 [cited 2023 Jul 11]. Available from: https://www.julkari.fi/handle/10024/110860
   Google Scholar
• Steffen R, Erber W, Schmitt HJ. Can the booster interval for the tick-borne encephalitis (TBE) vaccine ‘FSME-IMMUN’ be prolonged? — a systematic review. Ticks Tick Borne Dis. 2021;12(5):101779. doi: 10.1016/j.ttbdis.2021.101779
   PubMed Web of Science ®Google Scholar
• Schöndorf I, Beran J, Cizkova D, et al. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine. 2007;25(8):1470–1475. doi: 10.1016/j.vaccine.2006.10.028
   PubMed Web of Science ®Google Scholar
• Schoendorf I, Ternak G, Oroszlàn G, et al. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum Vaccin. 2007;3(2):42–47. doi: 10.4161/hv.3.2.3747
   PubMed Web of Science ®Google Scholar
• Wittermann C, Petri E, Zent O. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur® children. Vaccine. 2009;27(10):1585–1588. doi: 10.1016/j.vaccine.2008.12.057
   PubMed Web of Science ®Google Scholar
• Wittermann C, Izu A, Petri E, et al. Five year follow-up after primary vaccination against tick-borne encephalitis in children. Vaccine. 2015;33(15):1824–1829. doi: 10.1016/j.vaccine.2015.02.038
   PubMed Web of Science ®Google Scholar
• Holzmann H, Kundi M, Stiasny K, et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol. 1996;48(1):102–107. doi: 10.1002/(SICI)1096-9071(199601)48:1<102:AID-JMV16>3.0.CO;2-I
   PubMed Web of Science ®Google Scholar
• Beran J, Xie F, Zent O. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety. Vaccine. 2014;32(34):4275–4280.
   PubMed Web of Science ®Google Scholar
• Beran J, Lattanzi M, Xie F, et al. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence. Vaccine. 2019;37(32):4623–4629. doi: 10.1016/j.vaccine.2017.12.081
   PubMed Web of Science ®Google Scholar
• Beran J, Lattanzi M, Costantini M, et al. Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: third 5-year follow-up. Vaccine. 2023;41(23):3518–3524. doi: 10.1016/j.vaccine.2023.04.061
   PubMed Web of Science ®Google Scholar
• Allen JC, Toapanta FR, Chen W, et al. Understanding immunosenescence and its impact on vaccination of older adults. Vaccine. 2020;38(52):8264–8272. doi: 10.1016/j.vaccine.2020.11.002
   PubMed Web of Science ®Google Scholar
• Costantini M, Callegaro A, Beran J, et al. Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules. Hum Vaccin Immunother. 2020;16(9):2274–2279. doi: 10.1080/21645515.2019.1700712
   PubMed Web of Science ®Google Scholar
• Heinz F, Stiasny K, Holzmann H, et al. Vaccination and tick-borne encephalitis, Central Europe. Emerg Infect Dis. 2013;19(1):69–76. doi: 10.3201/eid1901.120458
   PubMed Web of Science ®Google Scholar
• Baroutsou V, Zens KD, Sinniger P, et al. Analysis of tick-borne encephalitis vaccination coverage and compliance in adults in Switzerland, 2018. Vaccine. 2020;38(49):7825–7833. doi: 10.1016/j.vaccine.2020.10.022
   PubMed Web of Science ®Google Scholar
• Zens KD, Haile SR, Schmidt AJ, et al. Retrospective, matched case–control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006–2020. BMJ Open. 2022;12(4):e061228. doi: 10.1136/bmjopen-2022-061228
   PubMed Web of Science ®Google Scholar
• Nygren TM, Pilic A, Böhmer MM, et al. Tick-borne encephalitis vaccine effectiveness and barriers to vaccination in Germany. Sci Rep. 2022;12(1):11706. doi: 10.1038/s41598-022-15447-5
   PubMed Web of Science ®Google Scholar
• Zavadska D, Freimane Z, Karelis G, et al. Effectiveness of tick-borne encephalitis vaccination in Latvia, 2018-2020: an observational study. Clin Microbiol Infect. 2023;29(11):1443–1448. doi: 10.1016/j.cmi.2023.06.028
   Web of Science ®Google Scholar
• Erber W, Khan F, Zavadska D, et al. Effectiveness of TBE vaccination in southern Germany and Latvia. Vaccine. 2022;40(5):819–825. doi: 10.1016/j.vaccine.2021.12.028
   PubMed Web of Science ®Google Scholar
• Konior R, Brzostek J, Poellabauer EM, et al. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults. Vaccine. 2017;35(28):3607–3613. doi: 10.1016/j.vaccine.2017.03.059
   PubMed Web of Science ®Google Scholar
• Kubinski M, Beicht J, Gerlach T, et al. Tick-borne encephalitis virus: A quest for better vaccines against a virus on the rise. Vaccines. 2020;8(3):451. doi: 10.3390/vaccines8030451
   Web of Science ®Google Scholar
• Schmidt AJ, Altpeter E, Graf S, et al. Tick-borne encephalitis (TBE) in Switzerland: does the prolongation of vaccine booster intervals result in an increased risk of breakthroughs? J Travel Med. 2022;29(2):taab158. doi: 10.1093/jtm/taab158
   PubMed Web of Science ®Google Scholar
• Santonja I, Stiasny K, Essl A, et al. Tick-borne encephalitis in vaccinated patients: a retrospective case-control study and analysis of vaccination field effectiveness in Austria from 2000 to 2018. J Infect Dis. 2023;227(4):512–521. doi: 10.1093/infdis/jiac075
   PubMed Web of Science ®Google Scholar
• Stiasny K, Aberle JH, Keller M, et al. Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis. PLoS One. 2012;7(3):e34145. doi: 10.1371/journal.pone.0034145
   PubMed Web of Science ®Google Scholar
• Hansson KE, Rosdahl A, Insulander M, et al. Tick-borne encephalitis vaccine failures: a 10-year retrospective study supporting the rationale for adding an extra priming dose in individuals starting at age 50 years. Clin Infect Dis. 2020;70(2):245–251. doi: 10.1093/cid/ciz176
   PubMed Web of Science ®Google Scholar
• Askling HH, Insulander M, Hergens M-P, et al. Tick borne encephalitis (TBE)-vaccination coverage and analysis of variables associated with vaccination, Sweden. Vaccine. 2015;33(38):4962–4968. doi: 10.1016/j.vaccine.2015.07.030
   PubMed Web of Science ®Google Scholar
• Lesnicar G, Poljak M, Seme K, et al. Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000. Pediatr Infect Dis J. 2003;22(7):612–617. doi: 10.1097/00006454-200307000-00009
   PubMed Web of Science ®Google Scholar
• Krbková L, Štroblová H, Bednářová J. Clinical course and sequelae for tick-borne encephalitis among children in South Moravia (Czech Republic). Eur J Pediatr. 2015;174(4):449–458. doi: 10.1007/s00431-014-2401-8
   PubMed Web of Science ®Google Scholar
• Zens KD, Baroutsou V, Sinniger P, et al. A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland. PLoS One. 2021;16(12):e0247216. doi: 10.1371/journal.pone.0247216
   PubMed Web of Science ®Google Scholar
• Slunge D, Boman A, Studahl M. Burden of tick-borne encephalitis, Sweden. Emerg Infect Dis. 2022;28(2):314–322. doi: 10.3201/eid2802.204324
   PubMed Web of Science ®Google Scholar
• Kunze M, Banović P, Bogovič P, et al. Recommendations to improve tick-borne encephalitis surveillance and vaccine uptake in Europe. Microorganisms. 2022;10(7):1283. doi: 10.3390/microorganisms10071283
   PubMed Web of Science ®Google Scholar
• Ethgen O, Cornier M, Chriv E, et al. The cost of vaccination throughout life: a Western European overview. Hum Vaccin Immunother. 2016;12(8):2029–2037. doi: 10.1080/21645515.2016.1154649
   PubMed Web of Science ®Google Scholar
• Weinberger B. Adult vaccination against tetanus and diphtheria: the European perspective. Clin Exp Immuno. 2017;187(1):93–99. doi: 10.1111/cei.12822
   PubMed Web of Science ®Google Scholar
• Institutul Național de Sănătate Publică Romania. Sistemul de supraveghere al infectiei cu virusul encefalitei de capusa. [cited 2023 Sep]. Available from: https://www.cnscbt.ro/index.php/metodologii/tbe/477-tbe-metodologie/file
   Google Scholar